PHILADELPHIA: Researchers have created a new method that might expedite efforts to identify and treat epilepsy before symptoms show up. Epilepsy cannot currently be diagnosed with a specific test, which makes the diagnosis challenging. The illness can be mistakenly diagnosed because it exhibits a wide range of symptoms and can resemble numerous other illnesses.
In a study published in the journal Lancet Neurology, US researchers claim to have created a method that could help identify abnormal proteins linked to the disease before symptoms manifest. This study demonstrates the efficacy of the alpha-synuclein seed amplification assay (alpha-synuclein-SAA) in identifying individuals at risk for the disease. The results of the study might make it easier to detect and treat the disease at an early stage.
Epilepsy rates have doubled globally over the past 25 years. One million people are now afflicted with this illness. Professor Andrew Sideroff, a co-author of the study and a professor at the University of Pennsylvania, suggested that identifying Parkinson’s disease markers that are particularly useful could be crucial for treating the condition.
Maryam's Blog 